Osteoarthritis

Changes to consultations and diagnosis of osteoarthritis in primary care during the COVID-19 pandemic

Osteoarthritis CartilagePublished Retrospective cohort study

Authors' conclusion

We observed 47% reduction in GP consultations for musculoskeletal disorders during the first wave and 9% during the second wave. For hip and knee OA/complaints, the reductions were over 50% during the first, and 10% during the second wave.

Study context

Population
Patients over 45 years of age in Dutch primary care, 2015–2020
Participants
118,756 participants
Exposure
General practitioners (GP) consultations in 2020 vs 5-year average
Outcome
GP consultations for any musculoskeletal complaints, knee and hip OA, knee and hip complaints, and newly diagnosed knee and hip OA/complaints
Methodological detailsprimary care consultation data 2015-2020, 2020 compared with 5-year average
  • Primary care consultation data 2015-2020
  • 2020 compared with 5-year average

Main finding

As reported in the abstract

Relative reduction in GP consultations, 2020 vs 5-year average · peak of the first wave

All musculoskeletal consultations, first wave peak

46.7%

95% CI 43.9–49.3%

Hip complaints, first wave peak

61.6%

95% CI 44.7–73.3%

All musculoskeletal consultations, second wave peak

9.3%

95% CI 5.7–12.7%

Knee osteoarthritis (OA), second wave peak

26.6%

95% CI 11.5–39.1%

Observational data: associations, not effects.

Further findings

Relative reduction in new diagnoses · peak of the first wave

Knee OA/complaints
87.0% (95% CI: 71.5-94.1%)
Hip OA/complaints
70.5% (95% CI: 37.7-86.0%)
New diagnoses at second wave peak: not statistically significant

Original publication

Changes to consultations and diagnosis of osteoarthritis in primary care during the COVID-19 pandemic. Osteoarthritis Cartilage. Published 5 March 2023. doi:10.1016/j.joca.2023.02.075

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.